Company intelligence / Profile preview

Jiangsu Logilet Biotech

Suzhou, Jiangsu, Chinapublications.gc.ca ↗

Ownership: Private
Employees: ~4
Development stage: Commercial

Overview

Jiangsu Logilet Biotech has developed the Logicore System, a fully automated, cartridge-based molecular diagnostic platform that integrates digital microfluidics with real-time PCR. This enables rapid, accurate point-of-care nucleic acid testing for infectious diseases. The system is designed to streamline sample-to-result workflows and improve accessibility of advanced molecular diagnostics outside central labs.

Therapeutic areas: Infectious Diseases
Modalities: DeviceMolecular diagnostics platform
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Jiangsu Logilet Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiangsu Logilet Biotech.

Explore the full profile